Bronstein, Gewirtz & Grossman announces class action lawsuit against Viatris

Bronstein, Gewirtz & Grossman notifies investors that a class action lawsuit has been filed against Viatris (VTRS) and certain of its officers. This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Viatris securities between August 8, 2024 and February 26 both dates inclusive. The Complaint alleges that Defendants provided investors with material information concerning the failed inspection of Viatris’ Indore, India facility. Specifically, the Complaint alleges that Defendants’ statements misrepresented the FDA’s issuance of a warning letter and its impact on Viatris’ operations and that Defendants routinely referred to the impact of the warning letter as a mere “minor headwind” for the Company. A class action lawsuit has already been filed. Bronstein, Gewirtz & Grossman, LLC is a nationally recognized firm that represents investors in securities fraud class actions and shareholder derivative suits. Our firm has recovered hundreds of millions of dollars for investors nationwide.